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Abstract: The standard treatment for breast cancer is surgical removal mainly through breast-
conserving surgery (BCS). We developed a new technique based on auto-fluorescence (AF)
spectral imaging and Raman spectroscopy for fast intraoperative assessment of excision margins
in BCS. A new wide-field AF imaging unit based on total internal reflection (TIR) was combined
with a Raman spectroscopy microscope equipped with a 785 nm laser. The wavelength of the
AF excitation was optimized to 365 nm in order to maximize the discrimination of adipose
tissue. This approach allows for the non-adipose regions of tissue, which are at a higher risk of
containing a tumor, to be targeted more efficiently by the Raman spectroscopy measurements.
The integrated TIR-AF-Raman was tested on small tissue samples as well as fresh wide local
excisions, delivering the analysis of the entire cruciate surface of BCS specimens (5.1× 7.6 cm2)
in less than 45 minutes and also providing information regarding the location of the tumor in the
specimen. Full automation of the instrument and selection of a faster translation stage would
allow for the measurement of BCS specimens within an intraoperative time scale (20 minutes).
This study demonstrates that the TIR-AF Raman microscope represents a feasible step towards
the development of a technique for intraoperative assessment of large WLE within intraoperative
timescales.
Published by The Optical Society under the terms of the Creative Commons Attribution 4.0 License. Further
distribution of this work must maintain attribution to the author(s) and the published article’s title, journal
citation, and DOI.
1. Introduction
Each year, it is estimated that approximately 270,000 and 55,000 new cases of breast cancer
are diagnosed in the USA and UK, respectively [1,2]. Standard treatment for operable breast
cancer involves surgical removal of the tumour typically using breast conserving surgery (BCS)
approaches. The excision specimen is examined post-operatively and completeness of excision
of the tumour is assessed through measurement of the distance between the tumour and the edge
of the specimen (surgical margin). [3] It is estimated that between 10 and 20% of BCS require a
second intervention (re-excision) because of positive margins involved by the tumour (tumour on
ink) including small tumour foci, which can be difficult to identify intraoperatively. [4–6]
One potential solution for reducing the number of re-excisions would be to use a technique that
can assess the surgical margins intra-operatively (within a reasonable time frame; typically less
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than 20 minutes). Several intra-operative techniques for the assessment of tumour margins have
been developed and tested, such as frozen sections, ultrasound probes, radiography, fluorescence
lifetime imaging and mass spectrometry. However, for each of these techniques, there are specific
limitations in terms of practicality, performance or cost-effectiveness [7,8]. Intra-operative
frozen section examination is a well-established method and can reduce the re-excision rates. [9]
However this method is laborious, it requires highly trained staff and it can lead to false results
due to sampling errors and the high rate of histological artefacts induced when processing fatty
samples [7,10]. For these reasons, the evaluation of surgical margins in breast specimens is often
performed on permanent section [11]. Therefore a new approach for intraoperative assessment of
margin that can overcome such limitations is urgently needed.
Raman spectroscopy is a promising candidate because it provides diagnosis of breast tissue
based on its chemical composition [12–16] providing quantitative analysis of the excised tissue
[15,17,18]. Raman spectral imaging based on raster-scanning is slow, as it can take up to two
hours to measure a 2× 2 mm2 tissue sample at the spatial resolution required to detect DCIS.
However, the length of time needed for the Raman analysis can be drastically reduced by the use of
selective-sampling Raman spectroscopy [19–23]. Previous work has demonstrated that selective-
sampling Raman spectroscopy can be successfully used to evaluate breast wide local excision
specimens (WLEs) [24,25]. This method used a multimodal approach, which incorporated
high-resolution confocal auto-fluorescence (AF) microscopy and Raman spectroscopy. A 405 nm
excitation and 511 nm long-pass emission system was used to obtain high-resolution AF-images,
and an algorithm was developed to divide the image into segments [25]. Raman spectra were
then acquired from the segments with lower AF intensity, which were typically more likely to
correspond to tumour, in order to establish a final label for each segment as either tumour or
normal breast tissues. This approach achieved 90% sensitivity at 80% specificity and analysis was
completed within 12–25 minutes for one side of the resection surface [22,25]. The main challenge
in these studies was related to the size and irregular surface of the lumpectomy specimens (which
limited analysis speed and accuracy) and the presence of blood. More recently, the use of Raman
bands in the high-wavenumber region for fast imaging of adipose tissue combined with fingerprint
Raman spectroscopy for classification of non-adipose tissue was also proposed for assessment of
surgical margins in breast excisions [26].
In this study we propose an alternative approach, in which Raman spectroscopy is combined
with wide-field auto-fluorescence spectral imaging in order to speed up tissue analysis. Blood
contains hemoglobin which is a strong chromophore, that shows an intense absorption peak
(Soret peak) at approximately 400 nm [27,28]. Thus, the use of 405 nm excitation, as used in
previous reports, can result in strong absorption of the light in the tissues [29]. As a result,
areas of adipose tissue that contained large quantities of blood appeared dark in the AF image
(due to the absorption by the blood) and healthy adipose tissue was unnecessarily selected for
the Raman analysis, increasing the overall tissue analysis time. To improve the performance
of AF imaging identifying adipose tissue and thus reduce the number of Raman spectra, we
investigated auto-fluorescence spectra of breast tissue using two excitation wavelengths: 405
nm (chosen to allow direct comparison with our previous work) and 365 nm (based upon a
preliminary literature study) [25,30,31]. Having tested both excitation wavelengths and identified
the preferred one, a device was developed and tested on small breast tissue samples to evaluate the
efficiency of wide-field total internal reflection imaging to perform auto- fluorescence imaging
and to identify/eliminate regions containing adipose tissue. The bespoke waveguide imaging unit
was then tested on ex-vivo wide local excisions (WLEs) to optimize the TIR_AF imaging step.
Once the imaging acquisition was optimized, the imaging unit was paired with, selective Raman
sampling and again first tested first on small tissue samples and subsequently on fresh wide local
excision. The image analysis was optimized to efficiently screen out the adipose tissue and an
algorithm was developed for the semi-automated screening of WLE within 30–45 minutes.
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2. Materials and methods
2.1. Tissue samples
Breast tissue samples were collected from patients undergoing breast cancer surgery at Nottingham
University Hospitals NHS Trust. The study was approved by the Nottingham Health Science
Biobank (NHSB, REC reference 15/NW/0685) and consent was obtained from all patients. The
investigation of WLE samples was approved by the Health Research Authority (19/EM/0251).
Two types of tissue samples were used for the experiments. The first type consisted of small
breast tissue samples taken from mastectomies and wide local excisions (WLE). Small tissue
samples (size varying from 10× 10 mm2 to 32× 40 mm2 and approximately 2–10 mm thick)
were used to perform fluorescence emission studies (13 samples) and collect preliminary test
data (6 samples). These samples were frozen and stored at −20 °C immediately after cutting,
until they were thawed for measurement. At the end of the experiments, the samples were fixed
and submitted for histological processing to obtain H&E sections of the analysed surface.
WLE resections (size up to 10× 10 cm2) were analysed fresh, within 1h from the surgery (16
samples). After the specimens were received from theatre they were prepared as follows: Step 1:
the specimen was dipped into black ink according the standard protocol, to keep track of the
margins of the specimen; Step 2: the specimen was incised from the inferior to the superior
margin to expose the tumour; Step 3: the exposed surface was blotted to remove excess blood and
biological fluids; Step 4 the sample was transferred to the instrument. (See Figure S1 Supplement
1).
2.2. Instrumentation
2.2.1. Fluorescence emission spectroscopy
Fluorescence emission spectra of human breast tissues were collected at two excitation wavelengths.
For 405 nm excitation, a confocal microscope (Nikon C2) with a 405 nm laser was used (Obis
405, Coherent). The emitted fluorescence light was analysed by a spectrometer equipped with a
300 lines/mm grating and silicon CCD (Andor Shamrock 303i). For 365 nm excitation, emission
light from a 190 mW LED was collimated and focused using optical lens for acquiring the
spectra (ThorLabs, M365L) using the same spectrometer for spectral analysis. For each sample,
several locations were analysed in order to account for tissue heterogeneity. At the end of the
experiments, the tissue samples were fixed, sectioned and stained to obtain the H&E sections of
the tested surface. A trained pathologist identified the type of tissue (labelled as adipose tissues,
stroma or tumour) at all locations where fluorescence spectra had been recorded.
2.2.2. Total internal reflection (TIR) fluorescence spectral imaging
A schematic of the TIR-fluorescence microscope is shown in Fig. 1. For excitation, four 365
nm wavelength LEDs (single LEDs typical power 360 mW) were mounted on an aluminium
enclosure designed to fit on a microscope stage.
The LEDs were tilted at an angle of approximately 150° with respect to the stage. A cylindrical
lens was used to focus the excitation light into an horizontal line in order to maximize coupling
into the 1 mm thick quartz slide (5.1× 7.6 cm2), on which the sample was placed. The quartz
slide was mounted on a removable aluminium sandwich sealed by an O-ring on either side of
the slide. The removable sandwich was built to allow better cleaning of the set-up after each
experiment. Considering the mismatch between the refractive indices of quartz (nq=1.54) and air
(nt=1.0003), the angle of incidence of the excitation light was larger than the critical angle (θc)
leading to total internal reflection and waveguiding of the excitation light in the quartz slide. The
evanescent field interacts with material that is in intimate contact with the quartz slide and can be
used to excite auto-fluorescence in the near surface region of the tissue.
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Fig. 1. Schematic representation of the LED based waveguide TIRF system: the instrument
is powered by four LEDs mounted on an aluminium holder that supports a quartz slide (1mm
thick) on which human tissue is placed. The light coming out of the tissues is collected
with an objective (Obj). The objective is switched between 1x, for AF module and 60x for
the Raman Module. In the AF imaging system, totally internally reflected light from the
LEDs is scattered at the waveguide surface (quartz slide). The incoming light with incident
angle greater than 48° is trapped in the quartz slide and undergoes total internal reflection
generating an evanescence field on either side of the quartz slide. The incoming light, with
angles less than 48°, refracts out into the other side of the cover glass and are absorbed by
the black O-ring.
The tissue samples were pressed into contact with the quartz slide using a 800 g weight
designed for the experiments. Fluorescence images were acquired using a Nikon CFI Plan 1x/0.04
UW objective and a QImaging QIClick CCD Camera (6.45 µm pixel size). The instrument
was controlled using software written in LabView (National Instruments). The microscope was
equipped with two band pass filters that allowed different optical spectral regions of interested
to be selected based on the results obtained from the fluorescence spectroscopy experiments.
The first band pass filter selectively allowed light with wavelengths between 442 to 488 nm to
pass and rejects all wavelengths outside this range (Filter 1). The second band pass filter only
transmitted wavelengths between 480 and 562 nm (Filter 2). These two filters were used to obtain
two separate TIR-AF images by manually switching between them during the experiments.
Once the TIR-AF images were acquired, purpose-developed software in Matlab (Mathworks)
was used for processing. A virtual mask was applied to remove the background areas and isolate
the area containing the tissue in the AF images. The virtual mask removes the background based
on an intensity threshold that is manually adjusted by the user to ensure that the area of the
images that do not contain tissue is removed [25]. Once the two AF images had been masked in
this way, the image obtained from Filter 1 was divided by the image obtained from Filter 2 to
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obtain a ratiometric image (See TIR-AF imaging system). The resulting ratiometric images were
then directly compared to H&Es of the same tissues with the support of a trained pathologist.
Subsequently, different thresholds were applied to the ratiometric image to perform multi-level
thresholding in order to identify ratio values that allow the isolation of stroma and tumour tissues
while screening-out the majority of the adipose tissue. The ratio values selected were: 0.8<T<2
and 1<T<2 (see Results and Discussion).
2.2.3. Combined TIR-AF imaging and Raman spectroscopy
The TIR-AF imaging system was combined with Raman Spectroscopy, which was implemented
on the same optical microscope. An auto-focusing system for the z-axis was established so the
sample was kept in focus during the Raman measurements.
Excitation for Raman spectroscopy was performed using a 785 nm CW laser (XTRA, Toptica).
The laser was focused on the sample by a 60x, 0.85 NA objective that was optimized for Raman
spectroscopy (River Diagnostics) and the laser power at the sample was 150 mW. Scattered
light was collected through the same objective and delivered to a spectrometer (Oriel 77 200,
Newport) and charge coupled device (CCD) camera (iDus DU-401-A-RR-DD, Andor) using a
dichroic mirror, a longpass filter (RT785rdc and RET792lp, Chroma) and focused by a 25 mm
focal length lens (AC127-025-B-ML, Thorlabs) to a 100 µm core optical fibre. Spectra were
detected over the range of 600–1800 cm−1.
After the images were collected using the two filters and processed to obtain the ratiometric
image, Raman raster scan experiments were performed by manually selecting multiple regions
identified from the thresholded ratiometric TIR-AF image. The acquisition time for the Raman
spectra was 3 s. Scanned areas ranged from 3× 4 to 20× 16 mm2 with 50–100 µm step-sizes.
Raman spectroscopy measurements were performed at locations independently determined by
a selective sampling algorithm. The algorithm first performs threshold (T) analysis of the TIR-AF
ratiometric image using the two ranges previously described (0.2<T<0.8 and 0.8<T<2). Values
between 0.8 and 2 were selected for further segmentation by performing k-means cluster analysis.
For samples with extended fibrosis, it was observed that the fibrosis areas were characterised by
values of the intensity ratio lower than 1, therefore for those samples the range selected for further
cluster analysis was restricted to 1<T<2. This analysis partitions the dataset into a number (K)
of pre-defined, non-overlapping clusters in which each data point belongs to only one cluster
[32]. The size of the segments (measured in pixels) was input by the user based on the size
of the specimen, for small tissue sample it was fixed to 1000 px while for WLE it varied from
5000 up to 12000 px with the number of segments varying from 28 to 83 based on the size of
the specimen and the area isolated by the algorithm for the clustering analysis. The segmented
images were used to generate Raman sampling points. The number and location of measurement
points were determined as previously described [20], with a minimum of 3 points per segment
and keeping the total Raman spectral acquisition time to be approximately 15 minutes.
The acquisition time for each Raman spectra was set to 3.5 s. The processing of Raman spectra
included cosmic ray removal, spectral-response correction using a NIST fluorescence standard
(SRM 2241, NIST), wavenumber calibration using polystyrene as a reference, background
subtraction [33], and smoothing [34] . Raman spectra with intensities larger than 3000 counts at
780 cm−1 were discarded (due to fluorescence interference), as were spectra with signal-to-noise
ratios lower than 15.5 (signal to noise ratio was calculated as the ratio of the intensity of the at
1450 cm−1, CH2 scissors peak, divided by the standard deviation of intensities in the relatively
quiet range 1370–1410 cm−1).
3. Results
Previous studies have reported that tumours have lower concentration of collagen and FAD
compared to normal breast tissue, as well as a higher concentrations of both NADPH, NADH,
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protoporphyrin and protein when compared to stroma [30]. In contrast, lipopigments (e.g. ceroids,
lipofuscin) are more abundant in adipose tissue [31]. However, auto-fluorescence intensity
can vary due to fluorophore environmental factors (such as the presence of blood or increased
concentration of lipopigments in the tissues due to the diet of the patient). To avoid errors due to
auto-fluorescence intensity variations, we investigated the feasibility of ratiometric fluorescence
imaging by calculating an image as the ratio of two fluorescence images obtained from two
different spectral ranges. Ratiometic imaging has the advantage of providing a self-calibration for
the signal by eliminating environmental variations, as well as other experimental conditions (e.g.
variations in excitation intensity, contact between tissue and quartz window). We investigated
two excitation wavelengths (405 nm and 365 nm excitation) in order to identify fluorescence
spectral differences between stroma, tumour and adipose tissue, which could then be used for
ratiometric imaging.
Breast tissue is highly heterogeneous, therefore fluorescence spectra were collected at different
locations on the sample surface, and then H&E sections were obtained to assign a class (tumour,
stroma or adipose tissue) to each spectrum. This process is illustrated in Fig. 2(a)–(c) for a typical
tissue sample, using the 365 nm excitation wavelength. The emission spectra corresponding to
adipose tissue have two intense peaks at 475 nm and 500 nm and two smaller peaks at 550 nm
and 595 nm. The positions of these peaks are consistent with data reported in the literature for
healthy breast tissues and adipose breast tissue, and were assigned to vitamins, lipopigments and
porphyrin, respectively [35]. In contrast, the emission spectra of tumour and stroma are very
similar, showing an intense peak at approximately 460 nm that can be assigned to NADPH and
NADH [30,35]. The mean fluorescence emission spectra corresponding to 365 nm excitation
that were collected from ten samples obtained from ten patients are presented in Fig. 2(d). The
results show that the 550 nm peak in the spectra of adipose tissue, typical of lipogiments, is
consistent among the different samples studied and can be clearly resolved from other spectral
features. However, the results show that no significant differences exist between the emission
spectra of stroma and tumour, when 365 nm light is used for excitation.
The fluorescence emission spectra of breast tissue measured using 405 nm excitation wavelength
are presented in Fig. 3. Similar to Fig. 2, Fig. 3(a)–(c) show the results for a typical breast tissue
containing tumour, stroma and adipose tissue. However, compared to the spectra obtained at 365
nm excitation, the results in Fig. 3(b) show only minor spectral differences between the tissue
types. The spectra measured at locations corresponding to adipose tissue have an intense peak at
∼500 nm while a similar peak can be observed at ∼490 nm for tumour and stroma. The mean
spectra obtained from six samples (six patients) confirmed these findings (Fig. 3(d)). Comparing
the results of the fluorescence emission spectra obtained with 365 nm and 405 nm excitation
wavelengths, it was concluded that 365 nm wavelength provided larger spectral differences
between adipose tissue and the other tissue types. The 365nm excitation wavelength was therefore
selected for use in TIR-AF imaging.
Figure 4 compares the TIR-AF images for typical breast tissue samples with the adjacent H&E
stained sections. Fluorescence emission images obtained with the Filter 1 (442 to 488nm) and
Filter 2 (480 to 562nm) were acquired using the TIR-AF imaging unit (shown in Fig. 1), using a
365 nm excitation wavelength. After optimisation of the main microscope and camera parameters
(camera gain, resolution, speed of the microscope translation stage), TIR-AF images of an area of
2× 4 cm2 of tissue were acquired in 4 minutes (1.6 minutes for actual image acquisition and 2.4
minutes required for scanning the sample using the microscope translation stage, see Supplement
1 section 3).
The sample in Fig. 4(a) contained both normal breast tissue (adipose tissue and stroma) and
tumour, while the sample in Fig. 4(b) consisted only of normal breast tissue. In the individual
images recorded with each filter, Fig. 4 shows that adipose tissue has higher fluorescence intensity
compared to stroma and tumour. A greater consistency was obtained between samples from
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Fig. 2. Fluorescence emission spectra of breast tissue obtained using a 365 nm excitation
wavelength. a) White light photograph of a typical tissue sample, the blue dots indicate
the locations from which the spectra were collected. b) Normalised fluorescence emission
spectra corresponding to tumour, stroma and adipose tissue for the sample presented in a).
c) H&E stained section of the sample presented in a), with the collection locations of the
spectra marked by the dots colour coded based on the assigned class (tumour, stroma, adipose
tissue). d) Mean fluorescence emission spectra from 10 samples (10 different patients). The
shadings show the standard deviation.
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Fig. 3. Fluorescence emission spectra of breast tissue obtained using a 405 nm excitation
wavelength. a) White light photograph of a typical tissue sample, the blue dots correspond
to the locations from which spectra were collected. b) Normalised fluorescence emission
spectra corresponding to tumour, stroma and adipose tissue for the sample presented in a). c)
H&E stained section of the sample presented in a), the dots correspond to the location from
where the spectra were collected and are represented colour coded based on the assigned
class (tumour, stroma, adipose tissue). d) Mean fluorescence emission spectra from 6
samples (6 different patients). The shadings show the standard deviation.
different patients when calculating ratiometric images (Fig. 4, Filter1/Filter2). The majority
of the adipose tissue areas are characterized by ratio values that are typically smaller than 1,
while tumour and stroma have values in the range 1–2. These results are in agreement with the
emission intensity spectra in Fig. 2. The adipose tissue has an intense band corresponding to
Filter 2 (480 to 562nm) and therefore it is expected that the ratio values would be lower compared
to tumour and stroma. Although regions of adipose tissue in Fig. 4(b) appear to have ratio values
higher than 1, it is important to note here that the aim of the TIR-AF imaging is to exclude as
much area of adipose tissue as possible, for the subsequent Raman spectroscopy measurements.
This means that although some areas of adipose tissue are incorrectly identified as tumour or
stroma, the area of the tissue that needs to be sampled using Raman measurements are greatly
reduced. However, it is worth stressing at this point that although adipose tissue was occasionally
misidentified as other tissue types using the TIR-AF techniques, tumour and stroma were never
misidentified as adipose tissue.
In order to identify consistent values in the ratiometric image that could allow for an automated
detection of adipose tissue, we performed multi-level thresholding to divide the ratiometric
images in to multiple regions based on different ratio values. The different regions isolated
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Fig. 4. TIR-AF imaging of typical breast tissue samples. a - Sample containing tumour,
stroma and adipose tissue. b- Sample containing only adipose tissue. The TIR-AF images
were collected using Filter 1 (442–488 nm) and, Filter 2 (480–562 nm), the ratiometic
images were calculated dividing image from Filter 1 by the image from Filter 2. The red
circle represents the tumour area, while green and blue circles highlight the adipose tissue
and stroma. The adjacent H&E stained sections (included for comparison). Additional
information in supplemental document Figure S2.
with different ratio value ranges were plotted in separate images and compared with the H&E
(supplemental document Figure S3). After the multi-level thresholding had been applied to all
the fluorescence ratiometric images (4 small tissue samples and 3 WLE), it was observed that
the adipose tissue consistently fell within ratio range 0.2 - 0.8 of the ratiometric images. All the
other tissue types (stroma, inflamed stroma and tumour) were consistently isolated by the ratio
range 0.8 - 2. Therefore, an algorithm was developed to apply a threshold value of T=0.8 to the
ratiometric images, and regions with values smaller than this threshold were labelled as “adipose
tissue”. This allows for the quick screening of adipose tissue that should also be insensitive
to inter-patient variations or tissue-slide contact. It is important to note here that when setting
the threshold, it is important that it is not set too low and no tumour is incorrectly classified as
adipose tissue and then excluded from Raman spectroscopy. The alternative is preferable, for
example areas of adipose tissue having ratio values above the threshold, in which case they will
be scanned by Raman spectroscopy.
To test the consistency of the T=0.8 threshold, we recorded TIR-AF ratiometric images from
new breast tissue samples and we compared Raman spectra recorded at locations of tissue
corresponding to ratio values smaller and larger than the threshold value. This was achieved by
manually moving the sample to the selected regions after the analysis of the TIR-AF image while
the sample was still on the microscope stage. This test would overcome potential inconsistencies
when comparing the TIR-AF and H&E images. This is because, although H&E staining was the
standard of reference, it was not possible to overlap the H&E images and the TIR-AF images with
sufficient accuracy, because the tissue processing required for H&E staining altered the overall
shape of the tissue. On the other hand, the differences between the Raman spectra of adipose
tissue, stroma and tumour are well established [14,36]. Fig. 5(a) and (b) show the ratiometric
TIR-AF image and the segmented images using T=0.8 for two breast tissue sample obtained
from two different patients. Sample a) contained stroma and adipose tissue; sample b) contains
tumour stroma and adipose tissue. For sample a) Raman spectra collected from the areas of the
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tissue corresponding to ratio values between 0.2 and 0.8 (below threshold T=0.8) showed Raman
spectra typical of adipose tissues, as characterised by a peak 1655 cm−1, (assigned to C=C in
lipids), an intense peak at 1441 cm−1, (assigned to CH2 deformation of the lipids), two peaks
at 1260 cm−1 and 1275 cm−1 (assigned to=CH deformations) and the complex peaks between
1080–1095 cm−1(assigned to skeletal vibration and PO2 vibrations). [14,16,24,37] On the other
hand, the Raman spectra measured from the regions within ratio values above the threshold
T=0.8 (and smaller than 2) presented typical Raman spectral features associated with stromal
tissue, such as bands assigned to collagen peaks at 860 cm−1 and 938 cm−1 and the phenylalanine
peak at 1004 cm−1 [14,24,25,36,38]. Raman analysis of the tissues is supported by the H&E
staining that indicate large areas of adipose tissue and small regions of stroma.
For the sample in Figure5b, which contains a large area of tumour surrounded by adipose
tissues, the spectra collected from areas within the 0.8 and 2 range (above threshold T=0.8)
have similar bands to Raman spectra of breast tumour reported previously. [22,34,35,36,37]
In particular, the peak at ∼1004 cm−1 associated with the phenylalanine of the proteins (which
are largely abundant in tumour cells compared to healthy cells), the peak at 1655 cm−1 in the
amide I and the peaks corresponding to collagen at 860 cm−1, 938 cm−1, which are less intense
than the band at 1004 cm−1, have been previously reported as typical of tumour tissue Raman
spectra. The corresponding area on the H&E staining confirms that the area analysed by Raman
corresponds to large areas of tumour.
Fig. 5. a- Breast tissue sample containing adipose tissue and stroma. The green and
blue boxes indicate the location selected for the Raman measurement. The figure reports:
ratiometric AF image, threshold image (T<0.8), H&E staining and the average of Raman
spectra acquired from the area corresponding to the areas highlighted by the squares: adipose
tissue (green spectra) and region of the tissues containing stroma (blue spectrum). The
grey shadow overlaid with the spectra represents the standard deviation. The spectra were
overlaid and shifted vertically for clarity. b. Breast tissue sample containing adipose tissue,
stroma and tumour. The red boxes indicate the location selected for the Raman measurement.
The image reports: ratiometric AF image, threshold image (0.8<T<2), H&E staining and
the average of the Raman spectra acquired from the different locations. The spectra were
presented as in sample a. The H&Es were obtained from the mirror image tissue so it does
not overlap fully with the tissues image reported.
Research Article Vol. 12, No. 2 / 1 February 2021 / Biomedical Optics Express 950
Next, we investigated the feasibility of using the segmented ratiometric TIR-AF images to
generate sampling points for Raman spectroscopy in order to speed up the diagnosis of wide
local excision specimens. Here, the tissue surface exposed tissue during this cruciation was
used because it provides a better comparison with the H&E images (H&E of the surface of the
lumpectomy specimens cannot be obtained with the standard histology process). Furthermore, by
analysing the cruciate surface we obtain, with one single image, a snapshot of the position of the
tumor and the relative distance from the edge of the tissue which is what is measured as margins.
To obtain a diagnosis of a tissue sample, the segments in the ratiometric image with ratio
values smaller that a threshold T=0.8 were labelled as “adipose tissue” and excluded from any
further analysis. Figure 6 shows an example of multiodal analysis using TIR-AF ratiometric
approach to guide Raman spectroscopy analysis of a WLE containing a phylloydes tumour, a
form of tumour for which surgical removal is the preferred strategy [39]. As confirmed by the
H&E staining, TIR-AF identified the adipose tissue and efficiently focused the Raman spectra at
the tissue location corresponding to the tumour (a total of 168 sampling points). Figure 6 shows
the processed Raman spectra from different locations as well as the average of Raman spectra.
The TIR-AF image acquisition for the WLE was set to 12 minutes while the integration time for
the individual Raman measurements was fixed to 3.5 s, leading to ∼45 minutes overall analysis
for the cruciate surface. Comparison of the H&E with the threshold AF image and Raman
analysis, confirmed that the adipose tissue was efficiently screened out by the imaging step and
the area containing tumour was correctly identified by the Raman analysis.
Fig. 6. Combined TIR-AF and Raman spectroscopy analysis of a WLE specimen containing
a phyllodes tumour. a- wide field (white light) image. B- ratiometric TIR-AF image. C-
H&E stained section. d- threshold image (0.8<T<2) with the sampling locations for the
Raman spectroscopy overlaid as yellow dots. Few locations have been highlighted and the
average Raman spectra are reported in e. The two blue dots correspond to stroma, 6 red
dots correspond to tumour and the two green dots correspond to adipose tissue. e- Raman
spectra (processed) from the corresponding locations reported in red, blue and green while
in black is the average of all the Raman spectra. The grey shadowing represents the standard
deviation.
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4. Discussion
Previous studies showed that the combination of auto-fluorescence imaging and Raman spec-
troscopy can be a powerful approach for analysis of breast tissue samples [22,40,41]. However,
the application for breast surgery has been limited because of the nature, as well as the size of
the samples. Compared to confocal fluorescence imaging using the 405 nm laser previously
reported [25], the TIR-AF takes advantage of the characteristic fluorescence spectra of adipose
tissue that enables its rapid identification. Compared to fluorescence intensity, the ratiometric
approach overcomes potential variations in fluorescence intensity caused by the presence of
blood, interpatient variation, spatial variations in excitation intensity and the quality of tissue
contact with the quartz slide. The confocal set-up reported previously [25] was not efficient in
screening out adipose tissue. Therefore, even if the total analysis time would be similar, screening
out the adipose tissue by optimized excitation wavelength would allow a more efficient targeting
of the “higher-risk” non-adipose areas of the tissue, providing superior diagnosis.
As typical breast resection specimens contain large areas of adipose tissue, which is efficiently
identified by TIR-AF, only a small fraction of tissue surface needs to be subsequently analysed by
Raman spectroscopy. Even if TIR-AF cannot distinguish between tumour and stromal tissues, the
efficient screening of the adipose tissue allows to focus the Raman spectroscopy measurements on
stroma and tumour regions only where it can efficiently detect more subtle molecular differences
between the tissues. More efficient exclusion of adipose tissue enabled an 8-fold increase in the
acquisition time for each Raman spectrum and an increase in the signal to noise ratio.
Other important advantages of the TIR-AF system when compared to confocal AF are its
simplicity and low cost. The TIR-AF system consists of an aluminium unit, quartz slide, LEDs
for excitation and CMOS camera for image acquisition. The system is easy to align and operate as
it does not require scanning elements. The use of the waveguide also makes the imaging system
versatile, as LEDs come in a wide range of excitation wavelengths and the same waveguide unit
can be easily adapted to investigate other types of tumour. The use of LEDs as the power source
to illuminate a waveguide has the advantage of limiting the variation in intensity of the evanescent
field that interacts with the sample compared to lasers, because the light source illuminates the
entire surface simultaneously [42].
The current experimental set-up, adapted from a pre-existing microscope, allowed us to
successfully measure large specimens within 45 minutes. TIR-AF images were acquired in 15
minutes (of which 13 minutes were used by the translational stage to move and to manually
switch between the two filters), Raman analysis was performed in approximately 14 minutes and
the rest of the time was used by the user to manually export the images and feed them into the
algorithm to obtain the sampling points. The optimized discrimination of the adipose tissue
using TIR –AF imaging, which better targeted high-risk areas allow to reduce the number of
Raman spectra that needed to be acquired which allowed for longer acquisition time (3.5s). The
longer acquisition time provides better SNR and thus better classification of the tissue structures.
Full automatization of the process (switch between AF and Raman), as well as more efficient
equipment (faster translation stage), will reduce the time for the screening of the specimen even
further, down to an estimated 20 minutes (5 minutes to obtain the ratiometric image and 15
minutes for the Raman measurements). Moreover, by performing the analysis on the dissected
(cruciated) specimen surface rather than from the outer excision surface, as previously reported
in the literature, the procedure allowed for the acquisition of a snapshot of the tumour as well as
the surplus healthy tissue surrounding it, as removed during surgery. This would allow for the
measurement of the distance between the edge of the specimen and the tumour (surgical margins)
at the end of the experiment (this could not be done by scanning the external surface of an intact
specimen given the limited penetration of both AF-TIR and Raman spectroscopy). Although
measuring the cruciated specimen would have the same limitations in terms of sampling errors as
standard histology, it may provide faster analysis compared to scanning the entire external surface
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of the tissue specimen (multiple tissue slices could analysed in parallel) and would allow direct
comparison to histology (obtaining histology section of the external surface of the entire tissue
specimen is very difficult and impractical). As the focus of this study was on establishing the
TIR-AF Raman system, we included only larger breast tumours (invasive carcinomas) in order
to avoid errors when comparing the TIR-AF images to the reference histology section. Future
studies will need to include smaller tumours, such as ductal carcinomas in-situ (DCIS), which
account for the majority of cases of positive margins.
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